Skip to main content

Hiberix Disease Interactions

There are 2 disease interactions with Hiberix (haemophilus b conjugate (prp-t) vaccine).

Major

Vaccines (applies to Hiberix) IM injection

Major Potential Hazard, Moderate plausibility. Applicable conditions: Thrombocytopenia, Thrombocytopathy, Coagulation Defect

In patients with thrombocytopenia or coagulation disorders, intramuscular injections may produce bleeding and hematomas. Patients with a platelet count less than 50,000/mm3 are at an increased risk. Caution is advised if the vaccine (e.g., plague vaccine, hepatitis A and B vaccines, and aluminum-adsorbed DTaP, DTP, DT, or Td) must be administered intramuscularly. The risk of bleeding may be minimized by vaccination immediately after the administration of replacement factor, use of a 23-gauge (or smaller) needle, and immediate application of direct pressure to the vaccination site for at least 2 minutes.

References

  1. "Product Information. Plague Vaccine (plague vaccine)." Greer Laboratories Inc PROD (2001):
  2. American Academy of Pediatrics. Committee on Infectious Diseases; Peter G, ed. "Red BooK: Report of the Committee on Infectious Diseases." Grove Village, IL: American Academy of Pediatrics (1997):
  3. "Product Information. Cholera Vaccine (cholera vaccine)." Wyeth-Ayerst Laboratories PROD
  4. "Product Information. Havrix (HepA) (hepatitis A adult vaccine)." SmithKline Beecham PROD
  5. "Product Information. Engerix-B (HepB) (hepatitis B adult vaccine)." Apothecon Inc (2022):
  6. "Product Information. Menactra (meningococcal conjugate vaccine)." sanofi pasteur (2005):
  7. "Product Information. ActHIB (Hib) (haemophilus b conjugate (PRP-T) vaccine)." sanofi pasteur (2022):
  8. "Product Information. Imogam Rabies-HT (rabies immune globulin, human)." sanofi pasteur (2010):
  9. "Product Information. Hyperrab S/D (rabies immune globulin, human)." Grifols Therapeutics (2015):
  10. "Product Information. Bexsero (meningococcal group B vaccine)." Novartis Vaccines & Diagnostics Inc (2022):
View all 10 references
Moderate

Vaccines (live attenuated/toxoid) (applies to Hiberix) immunocompromised

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Immunodeficiency

The expected antibody responses may not be obtained when live attenuated vaccines and/or toxoids are administered to immunosuppressed persons, including those receiving immunosuppressive therapy. Caution and close monitoring is advised.

References

  1. "Product Information. Menactra (meningococcal conjugate vaccine)." sanofi pasteur (2005):
  2. "Product Information. ActHIB (Hib) (haemophilus b conjugate (PRP-T) vaccine)." sanofi pasteur (2022):
  3. "Product Information. Bexsero (meningococcal group B vaccine)." Novartis Vaccines & Diagnostics Inc (2022):
  4. "Product Information. Trumenba (meningococcal group B vaccine)." Pfizer U.S. Pharmaceuticals Group (2022):
  5. "Product Information. Hiberix (Hib) (haemophilus b conjugate (PRP-T) vaccine)." GlaxoSmithKline (2022):
  6. "Product Information. Vaxchora (cholera vaccine, live)." PaxVax (2016):
  7. "Product Information. Vaxchora (cholera vaccine, live)." Emergent Travel Health, Inc (2022):
  8. "Product Information. Ixchiq (cvx 317) (chikungunya vaccine, live (cvx 317))." Valneva USA (2023):
View all 8 references

Hiberix drug interactions

There are 288 drug interactions with Hiberix (haemophilus b conjugate (prp-t) vaccine).

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer